Shanghai Simr Biotechnology Co., Ltd.

This study tested a new drug called SR750 in 138 people with trigeminal neuralgia, a condition that causes sudden, severe facial pain. Participants took either SR750 or a placebo for 6 weeks and recorded their daily pain levels. The goal was to see if SR750 reduces pain better th…

This early-stage study tested the drug SR750 in 40 healthy Chinese adults to see how safe it is and how the body processes it. Participants received either SR750 or a placebo in single or multiple doses. The goal was to gather basic safety and drug-level information, not to treat…